Slide Insurance Holdings, Inc. (NASDAQ: SLDE) disclosed a significant transaction by its top leadership on April 20, 2026. Bruce Lucas, who serves as the company's Chief Executive Officer, Director, and holds a ten percent ownership stake, sold 118,055 shares of common stock. The sale was executed through IIM Holdings II, LLC, an entity controlled by Lucas, resulting in total proceeds of approximately $2,307,975.
The transaction utilized a weighted average price of $19.55 per share, with individual transaction prices fluctuating between a low of $19.30 and a high of $19.79. This sale was not an ad hoc decision but was carried out pursuant to a pre-arranged 10b5-1 trading plan that Lucas had adopted on November 21, 2025. In accordance with standard reporting, Lucas disclaims beneficial ownership of these shares except for his specific pecuniary interest.
Concurrent Transactions and Ownership Structure
In addition to the sale by the CEO, a secondary transaction occurred on the same date involving Lucas's spouse. She sold 11,676 shares of common stock under a separate 10b5-1 trading plan, with prices ranging from $19.30 to $19.79 per share. Similar to the CEO, Lucas disclaims beneficial ownership of these specific securities outside of his pecuniary interest.
Following these recent sales, Bruce Lucas maintains a substantial direct holding of 1,137,546 shares of Slide Insurance Holdings common stock. His broader interest in the company is comprised of several indirect holdings:
- 37,052,987 shares held by IIM Holdings II, LLC
- 2,575,837 shares via the Bruce Lucas Irrevocable Grantor Retained Annuity Trust of 2014
- 208,101 shares beneficially owned by his spouse
- 1,370,898 shares held indirectly by his spouse through Securus Risk Management LLC
- 1,925,000 shares each held by the Emma Cloonen Irrevocable Trust and the Ava Cloonen Irrevocable Trust, for which Lucas serves as trustee
For these indirect positions, Lucas disclaims beneficial ownership except to the extent of his pecuniary interest.
Financial Performance and Market Context
The stock sale arrives during a period of notable price movement for SLDE. Over the last six months, the stock has seen returns of nearly 21%, although it was trading at $18.81 following recent activity. Despite the executive selling, analysis suggests the stock may be undervalued relative to its fair value, appearing on lists of undervalued opportunities. The company currently holds a valuation of $2.36 billion and maintains an "EXCELLENT" rating for financial health.
Recent fiscal data highlights the company's growth trajectory. Slide Insurance reported fourth-quarter 2025 earnings that outperformed analyst projections. The firm posted earnings per share (EPS) of $1.23, which was a considerable beat over the anticipated $0.71. Revenue for the period reached $347 million, an increase from the $238.5 million reported in the previous year. Strategic capital management has also been evident, with the company completing a $120 million stock repurchase program and authorizing a subsequent $125 million buyback program.
Analyst Outlook
Market professionals have maintained a generally positive outlook on the insurance provider. Barclays has sustained an Overweight rating with a price target of $29. Texas Capital Securities initiated coverage with a Buy rating and a $25 price target. Furthermore, Keefe, Bruyette & Woods recently increased its price target from $22 to $23, citing the strength of the fourth-quarter results and favorable trends within the company.
Investors are now looking toward the next major financial milestone, as the company is scheduled to report earnings on April 28.